Jefferies Healthcare Conference: How CDMOs are embracing the obesity drugs craze
Weight loss drugs known as GLP-1s have caused a stir among patients and investors, with many CDMOs now looking to tap into the booming market.
Stay updated with breaking news from David Windley. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Weight loss drugs known as GLP-1s have caused a stir among patients and investors, with many CDMOs now looking to tap into the booming market.
Weight loss drugs known as GLP-1s have caused a stir among patients and investors, with many CDMOs now looking to tap into the booming market.
Medpace Holdings, Inc. (NASDAQ:MEDP) Q3 2023 Earnings Call Transcript October 24, 2023 Operator: Good day, ladies and gentlemen, and welcome to the Medpace Third Quarter 2023 Earnings Conference Call. [Operator Instructions] As a reminder, this call may be recorded. I would now like to introduce your host for today’s conference call, Lauren Morris, Medpace’s Director […]
Operator: Good day, ladies and gentlemen, and welcome to the Medpace Third Quarter 2023 Earnings Conference Call. [Operator Instructions] As a reminder, this call may be recorded.